OTCMKTS:LTUS Lotus Pharmaceuticals (LTUS) Stock Price, News & Analysis → [Webinar] A Deep Dive into Options Volatility: Skew & Relative Value (From OIC) (Ad) Free LTUS Stock Alerts $0.0040 0.00 (0.00%) (As of 05/9/2024 ET) Add Compare Share Share Today's Range$0.0040▼$0.004050-Day Range$0.0040▼$0.007552-Week Range$0.0035▼$0.0120VolumeN/AAverage Volume15,620 shsMarket Capitalization$13.47 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartHeadlinesStock AnalysisChartHeadlines Get Lotus Pharmaceuticals alerts: Email Address Ad Crypto 101 MediaElon Musk Secret Crypto Plot ExposedReports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market. Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account." Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run.Click here now to get your copy. About Lotus Pharmaceuticals Stock (OTCMKTS:LTUS)Lotus Pharmaceuticals, Inc. does not have significant operations. Previously, it was engaged in the development, manufacture, and sale of pharmaceuticals in the People's Republic of China. The company is based in Nashville, Tennessee.Read More LTUS Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart LTUS Stock News HeadlinesMay 7, 2024 | msn.comMTG Black Lotus Sold for $3 MillionMay 6, 2024 | msn.comMagic: The Gathering Black Lotus sells for record-breaking $3 millionMay 10, 2024 | OIC (Ad)[Webinar] A Deep Dive into Options Volatility: Skew & Relative ValueJoin us for an exploration of essential volatility concepts in our "Volatility Fundamentals II: Skew & Relative Value" session. OIC® instructor Ken Keating will guide you through important topics that options investors should understand. May 4, 2024 | yahoo.comWhat Should ‘The White Lotus’ Do Next? We Asked Designers, Somms, Travel Experts and MoreMay 2, 2024 | finance.yahoo.comEupraxia Pharmaceuticals Announces Gastrointestinal Clinical Advisory BoardApril 21, 2024 | msn.com73 Best TV Shows to Binge Watch (April 2024)April 18, 2024 | yahoo.comLotus’s New Electric SUV Is Coming This YearApril 16, 2024 | msn.comResearchers explore medicinal potential of lotus benzylisoquinoline alkaloidsMay 10, 2024 | OIC (Ad)[Webinar] A Deep Dive into Options Volatility: Skew & Relative ValueJoin us for an exploration of essential volatility concepts in our "Volatility Fundamentals II: Skew & Relative Value" session. OIC® instructor Ken Keating will guide you through important topics that options investors should understand. April 14, 2024 | au.news.yahoo.comModi promises India jobs, infrastructure if re-electedApril 14, 2024 | msn.comIndia's Modi promises jobs, infrastructure if BJP wins third termApril 12, 2024 | msn.comIs It a Miracle Drug or the Latest Showroom Sensation?April 12, 2024 | ca.finance.yahoo.comLotus Ventures Inc. (J.CN)April 10, 2024 | msn.comAnd Just Like That, Lotus Is an EV MakerApril 8, 2024 | finance.yahoo.comNRx Pharmaceuticals (NASDAQ:NRXP) Announces Data-Lock of Phase 2b/3 Trial of NRX-101 in Suicidal Treatment Resistant Bipolar DepressionApril 6, 2024 | msn.comLong-standing vegan restaurant Blossoming Lotus closes after two decades in PortlandApril 4, 2024 | msn.comFentanyl kills thousands of Americans. Could plugging a gap in U.S. intelligence save lives?April 3, 2024 | finance.yahoo.comQ4 2023 NRX Pharmaceuticals Inc Earnings CallApril 3, 2024 | msn.comThis Swiss Car Company Built A Scuba-Diving Lotus Elise EVApril 2, 2024 | msn.comSteel Lotus Fitness to raise money for Harrisburg police K9March 29, 2024 | msn.com‘1923’ Breakout Brandon Sklenar To Co-Star Opposite Meghann Fahy In Christopher Landon’s ‘Drop’ From Platinum Dunes And BlumhouseMarch 24, 2024 | msn.com‘The White Lotus’ Thailand is next. These hotels do it on a budget.March 11, 2024 | msn.comLotus’s New Electric Flagship: The Emeya Hyper GT SedanMarch 8, 2024 | msn.comLotus Emira Finally Cleared For Sale In U.S. After Three YearsFebruary 26, 2024 | msn.comA former resident of The World cruise ship spent 6 years onboard, says it's not unlike 'The White Lotus'February 26, 2024 | msn.comEV maker Lotus Technology begins second week of trading after SPAC debutFebruary 26, 2024 | reuters.comChina securities regulator says penalties will be severe in market crackdownSee More Headlines Receive LTUS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Lotus Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today5/10/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Pharmaceutical preparations Sub-IndustryN/A Current SymbolOTCMKTS:LTUS CUSIPN/A CIKN/A Webwww.lotuspharma.com Phone(941) 267-9684Fax86-10-6389-9867Employees233Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket Cap$13.47 million OptionableNot Optionable Beta-0.36 The Best High-Yield Dividend Stocks for 2024Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.Get This Free Report Key ExecutivesDr. Zhong Yi Liu (Age 63)Founder, Chairman, Chief Executive Officer and President Comp: $180kMs. Yan Zeng (Age 55)Chief Financial Officer and Principal Accounting Officer Dr. Xing Shen (Age 53)Vice President of Corporate Development Key CompetitorsRedHill BiopharmaNASDAQ:RDHLNovelion TherapeuticsOTCMKTS:NVLNFPieris PharmaceuticalsNASDAQ:PIRSMonopar TherapeuticsNASDAQ:MNPRPurple BiotechNASDAQ:PPBTView All Competitors LTUS Stock Analysis - Frequently Asked Questions How have LTUS shares performed in 2024? Lotus Pharmaceuticals' stock was trading at $0.0043 at the beginning of the year. Since then, LTUS shares have decreased by 6.7% and is now trading at $0.0040. View the best growth stocks for 2024 here. How do I buy shares of Lotus Pharmaceuticals? Shares of LTUS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:LTUS) was last updated on 5/10/2024 by MarketBeat.com Staff From Our Partners[Webinar] A Deep Dive into Options Volatility: Skew & Relative ValueOICYou need to know these two things about AI stocks ASAP…InvestorPlaceThis 1 Biotech Stock has been shocking the marketsHuge AlertsTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaGold Set to EXPLODE!Gold Safe ExchangeShocking: One AI startup's revenue could surge 4,735%Manward PressForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingTrump Asset Seizure Threat Alert: Could Your Savings Be Next?American Hartford Gold Group Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lotus Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
